Correlation between Receptor Activator of Nuclear Factor-κβ Ligand (RANKL), and Osteoprotegerin (OPG) with Cartilage Degradation in Rheumatoid Arthritis Patients

Eitemau Tebyg

• Correlation between Receptor Activator of Nuclear Factor-κβ Ligand (RANKL), and Osteoprotegerin (OPG) with Cartilage Degradation in Rheumatoid Arthritis Patients
  gan: Rudy Hidayat, et al.
  Cyhoeddwyd: (2015-01-01)
• Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
  gan: Remuzgo-Martínez, Sara, et al.
  Cyhoeddwyd: (2016)
• Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
  gan: Wasilewska, Anna, et al.
  Cyhoeddwyd: (2010)
• Immunolocalization of receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice
  gan: Sakakura, Yasunori, et al.
  Cyhoeddwyd: (2005)
• Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
  gan: Siamak Kazemi-Sufi, et al.
  Cyhoeddwyd: (2024-09-01)